15.98USD+0.98%Mkt Cap: 836.84M USDP/E: —Last update: 2026-06-01
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap836.84M USD
Enterprise Value756.76M USD
Revenue (TTM)59.00K USD
Gross Profit59.00K USD
Net Income (TTM)-78.26M USD
Revenue/Share0.0040 USD
Last Price15.98 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees33
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.56
PEG—
EV/EBITDA-9.59
EV/Revenue12826.37
P/S14210.52
P/B5.75
EPS (TTM)-5.57
EPS (Forward)-2.87
52W Range
3.61060% of range24.27
52W High24.27 USD
52W Low3.610 USD
Profitability
Gross Margin100.00%
Oper. Margin-134164.40%
EBITDA Margin0.00%
Profit Margin-132642.37%
ROE-94.23%
ROA-67.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-51.46M USD
CapEx (TTM)—
FCF Margin-39401.91%
FCF Yield-2.78%
Net Debt-81.67M USD
Net Debt/EBITDA1.03
Balance Sheet
Debt/Equity0.00
Current Ratio7.66
Quick Ratio7.07
Book Value/Sh2.773 USD
Cash/Share1.560 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:240
Split DateDec 29, 2023
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)46.18 USD
Target Range34.00 USD – 60.00 USD
# Analysts11
Ownership
Shares Out.52.57M
Float45.95M
Insiders1.69%
Institutions68.98%
Short Interest
Short Ratio2.7d
Short % Float11.92%
Short % Out.11.90%
Shares Short6.25M
Short (prev mo.)5.24M
Technical
SMA 5015.61 (+2.3%)
SMA 20015.20 (+5.1%)
Beta0.79
S&P 52W Chg27.94%
Avg Vol (30d)2.11M
Avg Vol (10d)1.55M
Technical Indicators
RSI (14)45.4
MACD0.0117
MACD Signal0.3882
MACD Hist.-0.3766
BB Upper22.87 USD
BB Middle17.62 USD
BB Lower12.36 USD
BB Width59.68%
ATR (14)1.385 USD
Vol Ratio (20d)0.23x